바이오인

Patient Capital : How Venture Capital Investment Drives Revolutionary Medical Innovation

 

 

 

 

2   Executive Summary

6   Section I
     Venture Capitalists Are Committed to Investing In and Growing the Life Sciences Sector

9   Section II
     Venture Capital Saves Lives and Money by Funding Revolutionary
     Medical Breakthroughs

11 Section III
     Venture Capital Backed Life Sciences Investment Depends Upon a Predictable and   

     Efficient Path Within the Regulatory Environment

13  Section IV
     Venture Capital Contributes to Medical Innovation

    13 The Heart Attack Drug, Integrilin
    13 Blood Glucose Self-Monitoring
    14 Minimally Invasive Breast Biopsy
    14 Osteoporosis

16 Conclusion
     Venture Capital Drives the Next Generation of Cures

17 Venture Capital 101: What Is Venture Capital?

19 About the Author and the National Venture Capital Association

20 Endnotes

 

 

 

 

 

Patient Capital: How Venture Capital Investment Drives Revolutionary Medical Innovation demonstrates that many of the nation’s most innovative medical breakthroughs have been brought to market by billions of dollars of venture capital investment in life sciences companies. The economic impact and medical contributions of these life sciences companies have been enormous.1 The revolutionary medical breakthroughs produced by venture capital backed companies such as Amgen, Genentech, Genzyme, Gilead Sciences, Kyphon, Intuitive Surgical, and Scimed Life Systems, along with hundreds of smaller innovative life sciences companies, amount to highly tangible and valuable improvements to the U.S. economy and to people’s lives. Today, small venture backed companies often serve as the research and development (R&D) pipeline for the larger life sciences corporations who seek to acquire the most promising innovations. Whether these emerging companies someday grow to the size of a For tune 500 corporation or are acquired for their groundbreaking products, they all rely on the venture capital industry to get their start....계속